The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Galectin Therapeutics Inc

Nasdaq: GALT
Last

--

Today's change-- --
 Delayed by at least 15 minutes.
 

Galectin Therapeutics Inc

Nasdaq: GALT
Last

--

Today's change-- --
 Delayed by at least 15 minutes.

Key company metrics

  • Open--
  • Previous close--
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change--
  • Volume--
  • Average volume (10-day)--
  • Average volume (1-month)--
  • Average volume (3-month)--
  • 52-week range-- to --
  • Beta--
  • Trailing P/E--
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS--
 Delayed by at least 15 minutes.

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue------0
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense5556
Selling / general / administrative1111
Research & development4334
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-5-5-5-6
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-5-5-6
Income after tax-5-5-5-6
Income tax, total--------
Net income-5-5-5-6
Total adjustments to net income01-10
Net income before extra. items-5-5-5-6
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5-4-6-6
Inc. avail. to common incl. extra. items-5-4-6-6
Diluted net income-5-4-6-6
Dilution adjustment--------
Diluted weighted average shares34302929
Diluted EPS excluding extraordinary itemsvalue per share-0.15-0.13-0.19-0.20
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.15-0.13-0.19-0.20